Sun Pharmaceutical Industries LtdSUNPHARMA:NSI

625.60
5.65 / 0.91%
3.22m
31.57%
0.3818
Close in INRToday's changeShares traded1 year changeBeta
As of Apr 23 2014 11:28 BST.Data delayed by at least 15 minutes.

Summary

On Wednesday, Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) closed at 625.60, 4.25% below its 52-week high of 653.35, set on Mar 03, 2014.

52-week range
Today
457.85
Jun 13 2013
653.35
Mar 03 2014
Open616.50
Day high635.00
Day low616.50
Bid625.60
Offer--
Previous close619.95
Average volume2.85m
Shares outstanding2.07bn
Free float726.10m
P/E (TTM)49.22
Market cap1.28tn INR
EPS (TTM)12.60 INR
Annual div (TTM)2.50 INR
Annual div yield (TTM)0.40%
Div ex-dateSep 19 2013
Div pay-dateOct 30 2013

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sun Pharmaceutical Industries Ltd+1.63%+6.86%+1.01%+31.57%+431.97%
CNX NIFTY IDX+2.48%+5.33%+10.72%+17.20%+99.81%
IN/HEALTH CARE+0.58%+2.09%+3.00%+15.28%--
IN/PHARMACEUTICALS+0.50%+2.70%+1.96%+16.61%--
As of Apr 23 2014 11:28 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.